文献速递慢性肾脏病

非洲裔美国人中JC多瘤病毒尿症与慢性肾脏病保护相关且独立于APOL1基因型

JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

在200名新招募的非糖尿病非洲裔美国人中,尿JC多瘤病毒(JCPyV)在CKD病例中检出率8.8%,在无肾病对照中45.8%(P=3.0×10-8)。合并300名NHAANS参与者共500人分析显示,尿JCPyV阳性者CKD风险降低63%(OR 0.37;P=4.6×10-6)。BKPyV检出率在病例与对照间无差异(1.3% vs 0.8%,P=0.77)。

要点

  • 尿JCPyV阳性与非洲裔美国人非糖尿病CKD风险降低独立相关。
  • 该关联在携带与不携带APOL1肾脏风险基因型者中均存在。
  • BKPyV尿症与CKD无显著关联。

核心结论

  • 尿JCPyV与非洲裔美国人非糖尿病CKD呈负相关,且独立于APOL1基因型。

研究设计与样本

  • 研究对200名新招募的非糖尿病非洲裔美国人进行尿JCPyV和BKPyV的定量PCR检测。
  • 将上述200人与300名NHAANS参与者合并进行共500人的联合分析。

主要发现

  • 200名新参与者中,尿JCPyV在CKD病例检出率8.8%,无肾病对照45.8%(P=3.0×10-8)。
  • 携带APOL1肾脏风险基因型者中,JCPyV在病例检出5.1%,对照40.0%(P=0.0002)。
  • 不携带APOL1肾脏风险基因型者中,JCPyV在病例检出12.2%,对照48.8%(P=8.5×10-5)。
  • BKPyV在病例检出1.3%,对照0.8%(P=0.77)。
  • 联合分析500人中,尿JCPyV阳性者CKD风险降低63%(OR 0.37;P=4.6×10-6)。

关键数值与推荐

  • RNA荧光原位杂交证实非病变肾脏中存在JCPyV基因组DNA和JCPyV信使RNA(mRNA)。

临床怎么用

  • 尿JCPyV检测可能有助于非洲裔美国人非糖尿病CKD的风险分层,但需进一步验证。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Viral infections can trigger chronic kidney disease (CKD) and the urine virome may inform risk. The Natural History of APOL1-Associated Nephropathy Study (NHAANS) reported that urine JC polyomavirus (JCPyV) associated with a lower risk of APOL1-associated nephropathy in African Americans. Herein, association was assessed between urine JCPyV with CKD in African Americans independent from the APOL1 genotype. METHODS: Quantitative polymerase chain reaction was performed for urinary detection of JCPyV and BK polyoma virus (BKPyV) in 200 newly recruited nondiabetic African Americans. A combined analysis was performed in these individuals plus 300 NHAANS participants. RESULTS: In the 200 new participants, urine JCPyV was present in 8.8% of CKD cases and 45.8% of nonnephropathy controls (P = 3.0 × 10-8). In those with APOL1 renal-risk genotypes, JCPyV was detected in 5.1% of cases and 40.0% of controls (P = 0.0002). In those lacking APOL1 renal-risk genotypes, JCPyV was detected in 12.2% of cases and 48.8% of controls (P = 8.5 × 10-5). BKPyV was detected in 1.3% of cases and 0.8% of controls (P = 0.77). In a combined analysis with 300 NHAANS participants (n = 500), individuals with urine JCPyV had a 63% lower risk of CKD compared with those without urine JCPyV (odds ratio 0.37; P = 4.6 × 10-6). RNA fluorescence in situ hybridization confirmed the presence of JCPyV genomic DNA and JCPyV messenger RNA (mRNA) in nondiseased kidney. CONCLUSIONS: Inverse relationships exist between JCPyV viruria and non-diabetic CKD. Future studies should determine whether renal inflammation associated with CKD is less permissive for JCPyV reactivation/replication or whether JCPyV is a marker of reduced host immune responsiveness that diminishes immune pathologic contributions to CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Freedman BI, Kistler AL, Skewes-Cox P, et al. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans. Nephrol Dial Transplant. 2018. PMID: 29420808. doi:10.1093/ndt/gfx368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。